SAB Biotherapeutics, Inc. (SABS)
NASDAQ·Healthcare·Biotechnology
$3.79
+3.55%
Mkt Cap $33.17M
Analyst Ratings
Buy
6
Hold
0
Sell
0
Price Target (7 analysts)
$9.33
Range $7.00 – $11.00
Implied Upside
+146.2%
Consensus $9.33 vs current $3.79
NASDAQ·Healthcare·Biotechnology
$3.79
+3.55%
Mkt Cap $33.17M
Buy
6
Hold
0
Sell
0
Price Target (7 analysts)
$9.33
Range $7.00 – $11.00
+146.2%
Consensus $9.33 vs current $3.79